EXEL

Exelixis, Inc.NASDAQHealthcare

$43.88-0.36%ClosedMarket Cap: $11.76B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-02	RBC Capital	—	Sector Perform	—
2026-02-12	HC Wainwright & Co.	—	Buy	—
2026-02-11	Wells Fargo	—	Equal Weight	—
2026-02-11	Stifel	—	Hold	—
2026-02-04	Barclays	—	Equal Weight	—
2026-02-02	Morgan Stanley	—	Equal Weight	—
2026-01-08	HC Wainwright & Co.	—	Buy	—
2025-11-06	UBS	—	Neutral	—
2025-11-05	HC Wainwright & Co.	—	Buy	—
2025-11-05	Morgan Stanley	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Sun Jan 02	$3.92	$2.95B	11
Tue Jan 02	$4.77	$3.26B	12
Wed Jan 02	$5.57	$3.42B	5
Thu Jan 02	$5.48	$3.19B	6